Segall Bryant & Hamill LLC Acquires 42,840 Shares of BrightSpring Health Services, Inc. $BTSG

Segall Bryant & Hamill LLC raised its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 51.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 125,768 shares of the company’s stock after purchasing an additional 42,840 shares during the period. Segall Bryant & Hamill LLC owned 0.07% of BrightSpring Health Services worth $3,718,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of BTSG. Royce & Associates LP grew its position in shares of BrightSpring Health Services by 32.2% in the 3rd quarter. Royce & Associates LP now owns 182,538 shares of the company’s stock valued at $5,396,000 after buying an additional 44,505 shares during the last quarter. Group One Trading LLC lifted its stake in shares of BrightSpring Health Services by 755.7% in the third quarter. Group One Trading LLC now owns 12,852 shares of the company’s stock worth $380,000 after acquiring an additional 14,812 shares during the period. Handelsbanken Fonder AB bought a new stake in BrightSpring Health Services in the third quarter valued at approximately $248,000. Xponance Inc. acquired a new stake in BrightSpring Health Services during the 3rd quarter valued at approximately $219,000. Finally, TD Asset Management Inc raised its holdings in BrightSpring Health Services by 18.3% during the 3rd quarter. TD Asset Management Inc now owns 474,988 shares of the company’s stock worth $14,041,000 after purchasing an additional 73,308 shares during the last quarter.

BrightSpring Health Services Stock Down 0.5%

Shares of NASDAQ BTSG opened at $41.77 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.57 and a debt-to-equity ratio of 1.32. The firm has a market cap of $8.08 billion, a PE ratio of 47.47, a P/E/G ratio of 0.57 and a beta of 2.31. The company’s fifty day simple moving average is $39.42 and its 200 day simple moving average is $33.78. BrightSpring Health Services, Inc. has a 12-month low of $15.48 and a 12-month high of $44.87.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings data on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.01). The company had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. BrightSpring Health Services’s revenue for the quarter was up 29.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.11 EPS. As a group, sell-side analysts forecast that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

BrightSpring Health Services News Roundup

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Morgan Stanley raised its price target to $48 and kept an “overweight” rating, signaling analyst conviction and around mid-teens upside to recent levels. Article Title
• Positive Sentiment: Wells Fargo increased its price target to $50, another high-profile price-target lift that supports further upside expectations. Article Title
• Positive Sentiment: Zacks upgraded BTSG to a “Strong Buy” (Rank #1) and published multiple pieces noting momentum, inclusion on growth/momentum lists, and upward earnings-estimate revisions — all can attract buyers and algos. Article Title
• Positive Sentiment: Mizuho and other outlets flagged strong upside potential and noted elevated trading volume after analyst coverage changes — higher attention/liquidity can amplify moves. Article Title
• Neutral Sentiment: Several Zacks pieces compare BTSG favorably to peers and highlight it as a fast-moving value/momentum candidate; useful context but not a direct catalyst by itself. Article Title
• Neutral Sentiment: Short-interest reports in the feed show zero shares / NaN changes (data appears erroneous or not meaningful) — no reliable short-squeeze signal at present.
• Negative Sentiment: Most-recent quarterly results included a very slight EPS miss ($0.33 vs. $0.34 consensus) despite a revenue beat and strong year-over-year revenue growth; minor near-term headline risk for short-term traders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on BTSG shares. Cantor Fitzgerald set a $49.00 price objective on shares of BrightSpring Health Services in a research note on Monday. Wells Fargo & Company lifted their target price on shares of BrightSpring Health Services from $43.00 to $50.00 and gave the stock an “overweight” rating in a research note on Monday. Wall Street Zen cut shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 15th. BMO Capital Markets reissued an “outperform” rating and issued a $46.00 price objective on shares of BrightSpring Health Services in a research report on Friday, January 23rd. Finally, Mizuho boosted their price objective on BrightSpring Health Services from $45.00 to $50.00 and gave the company an “outperform” rating in a research note on Tuesday. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $44.08.

BrightSpring Health Services Profile

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.